M F Shiu - JoVE Visualize

Showing results (31-40 of 40) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 40 results.

British Heart Journal|November 1, 1991

Changes in Doppler indices of cardiac function during and after percutaneous transluminal coronary angioplastyA C Hunt, S C Chow, J Escaned, et al.

International Journal of Cardiology|February 22, 2001

Evaluation of patient characteristics and utilisation of invasive cardiac procedures in a UK ethnic population with unstable angina pectorisJ Trevelyan, E W Needham, M Halim, et al.

Heart (British Cardiac Society)|March 27, 1999

Coronary artery stenting in unstable angina pectoris: a comparison with stable angina pectorisP B Clarkson, M Halim, K K Ray, et al.

The Quarterly Journal of Medicine|January 1, 1980

The straight back syndromeM K Davies, P Mackintosh, R M Cayton, et al.

European Heart Journal|September 1, 1989

Balloon occlusion during coronary angioplasty as a model of myocardial ischaemia: reproducibility of sequential inflationsR A Perry, A Seth, A Hunt, et al.

British Heart Journal|May 1, 1990

Sustained improvement in left ventricular function after successful coronary angioplastyR A Perry, A Singh, A Seth, et al.

International Journal of Cardiac Imaging|January 1, 1990

An objective computer system for the quantification of artery stenosesP F Wankling, R A Perry, A Seth, et al.

Circulation|March 1, 1981

Oral prostaglandin E2 in ductus-dependent pulmonary circulationE D Silove, J Y Coe, M F Shiu, et al.

Zeitschrift Fur Kardiologie|August 1, 1997

[Low molecular weight heparin, reviparin, after PTCA: results of a randomized double-blind, standard heparin and placebo controlled multicenter study (REDUCE Study]M B Preisack, R Baildon, V Eschenfelder, et al.

Journal of the American College of Cardiology|November 15, 1996

Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Reduction of Restenosis After PTCA, Early Administration of Reviparin in a Double-Blind Unfractionated Heparin and Placebo-Controlled EvaluationK R Karsch, M B Preisack, R Baildon, et al.

Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 40 results.

British Heart Journal|November 1, 1991

Changes in Doppler indices of cardiac function during and after percutaneous transluminal coronary angioplastyA C Hunt, S C Chow, J Escaned, et al.

International Journal of Cardiology|February 22, 2001

Evaluation of patient characteristics and utilisation of invasive cardiac procedures in a UK ethnic population with unstable angina pectorisJ Trevelyan, E W Needham, M Halim, et al.

Heart (British Cardiac Society)|March 27, 1999

Coronary artery stenting in unstable angina pectoris: a comparison with stable angina pectorisP B Clarkson, M Halim, K K Ray, et al.

The Quarterly Journal of Medicine|January 1, 1980

The straight back syndromeM K Davies, P Mackintosh, R M Cayton, et al.

European Heart Journal|September 1, 1989

Balloon occlusion during coronary angioplasty as a model of myocardial ischaemia: reproducibility of sequential inflationsR A Perry, A Seth, A Hunt, et al.

British Heart Journal|May 1, 1990

Sustained improvement in left ventricular function after successful coronary angioplastyR A Perry, A Singh, A Seth, et al.

International Journal of Cardiac Imaging|January 1, 1990

An objective computer system for the quantification of artery stenosesP F Wankling, R A Perry, A Seth, et al.

Circulation|March 1, 1981

Oral prostaglandin E2 in ductus-dependent pulmonary circulationE D Silove, J Y Coe, M F Shiu, et al.

Zeitschrift Fur Kardiologie|August 1, 1997

[Low molecular weight heparin, reviparin, after PTCA: results of a randomized double-blind, standard heparin and placebo controlled multicenter study (REDUCE Study]M B Preisack, R Baildon, V Eschenfelder, et al.

Journal of the American College of Cardiology|November 15, 1996

Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Reduction of Restenosis After PTCA, Early Administration of Reviparin in a Double-Blind Unfractionated Heparin and Placebo-Controlled EvaluationK R Karsch, M B Preisack, R Baildon, et al.

Pageof 4